✨
AI Summary
- Raphaël Mazoyer, CEO of Finnrick, discusses their peptide testing database with over 10,000 results.
- Finnrick mystery-shops vendors, finding two-thirds of tested peptides are unapproved in the US.
- Analysis reveals low scores for some peptide vendors compared to retatrutide, with unexpected contents found.
Guests on This Episode
RM
Raphael Mazoyer
1 podcast appearance